Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate After Acute Myocardial Infarction With Modification of Cardiac Metabolomes and Anti-Oxidants in Diabetic Rats.

Journal of Pharmacology and Experimental Therapeutics - United States
doi 10.1124/jpet.118.253666
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Related search

Atorvastatin Enhances Interleukin-10 Levels and Improves Cardiac Function in Rats After Acute Myocardial Infarction

Clinical Science
Medicine
2008English

Correction: Testosterone Deficiency Reduces the Effects of Late Cardiac Remodeling After Acute Myocardial Infarction in Rats

PLoS ONE
Multidisciplinary
2019English

Temporary Transvenous Cardiac Pacing in Patients With Acute Myocardial Infarction Predicts Increased Mortality

Cardiology Research
Cardiovascular MedicineCardiology
2012English

Predictors of Mortality After Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction

Angiology
Cardiovascular MedicineCardiology
2018English

Socioeconomic Differentials in Recurrent Ischaemia and Mortality After Acute Myocardial Infarction

Heart
2001English

Brain Natriuretic Peptide and Cardiac Rupture After Acute Myocardial Infarction.

Internal Medicine
Internal MedicineMedicine
2001English

Albumin Excretion in Diabetic Patients in the Setting of Acute Myocardial Infarction: Association With 3-Year Mortality

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2004English

Heterogeneous Cardiac Sympathetic Innervation in Heart Failure After Myocardial Infarction of Rats

American Journal of Physiology - Heart and Circulatory Physiology
Cardiovascular MedicinePhysiologyCardiology
2000English

Heart Rate on Admission Is an Independent Risk Factor for Poor Cardiac Function and In-Hospital Death After Acute Myocardial Infarction

Journal of Cardiology
Cardiovascular MedicineCardiology
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy